Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alkem Laboratories is a leading Indian pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality medicines. The company is committed to research and development to provide innovative healthcare solutions for patients globally, thereby strengthening the healthcare sector.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alkem Laboratories is scheduled to report its next quarterly earnings on 11/06/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Alkem Laboratories last reported quarterly earnings on 8/14/2026 (Q2 2026). Earnings per share (EPS) came in at 43.50 INR.
Across its last 5 earnings reports, Alkem Laboratories stock moved by ±2.5% on average the following day. The largest reaction was -8% on 02/13/2026; 1 of 5 reactions were positive.
Alkem Laboratories has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.